Xenograft model for growth delay and survival studies

SP Salome Paillas
CT Chee K. Then
SK Susan Kilgas
JR Jia-Ling Ruan
JT James Thompson
AE Amy Elliott
SS Sean Smart
AK Anne E. Kiltie
ask Ask a question
Favorite

RT112 cells were prepared in phenol red-free Matrigel (BD Biosciences) and phosphate-buffered saline 1:1; 100 μL (5 × 106 cells) was injected into the flank of 6- to 7-week-old female CD1-nude mice. Mice were randomized in Excel (Microsoft) using RAND function into 4 groups: vehicle (5% DMSO in dH2O), romidepsin (4 mg/kg, single dose, intraperitoneally), IR (using a Gulmay-320 cabinet, 6 Gy, single dose), and romidepsin + IR (6 hours after romidepsin treatment). They received the corresponding treatment when the tumors reached 50 mm3. Tumors were measured 3-dimensionally 3 times a week with a manual calipers, and tumor volume was calculated using the formula (width × length × height × [π/6]). Mice were sacrificed when the tumors reached the limit size of 350 mm3.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A